Tìm kiếm
Akebia Therapeutics Inc
AKBAThêm vào danh sách theo dõi
0.963USD
+0.011+1.16%
Đóng cửa 09-14 16:00（ET）
261.69MVốn hóa
LỗP/E TTM
Thêm thông tin về Akebia Therapeutics Inc Công ty
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with two commercial products for patients impacted by kidney disease. The Company is focused on developing and commercializing therapeutics. Its two preclinical development candidates are AKB-9090 and AKB-10108. The Company’s portfolio and hypoxia-inducible factor (HIF)-based commercialized products include Auryxia (ferric citrate) and Vafseo. Auryxia (ferric citrate) is an orally administered medicine approved and marketed in the United States for two indications: the control of serum phosphorus levels in adult patients with dialysis dependent chronic kidney disease (DD-CKD), and the treatment of iron deficiency anemia (IDA), in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Vafseo, an oral HIF prolyl hydroxylase (HIF-PH), inhibitor. It utilizes third parties for the commercial distribution of Auryxia, including wholesale distributors and certain specialty pharmacy providers.
Akebia Therapeutics Inc Hồ sơ
Mã chứng khoánAKBA
Tên công tyAkebia Therapeutics Inc
Ngày IPOMar 20, 2014
Giám đốc điều hànhButler (John P)
Số lượng nhân viên181
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhMar 20
Địa chỉ245 First Street
Thành phốCAMBRIDGE
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện02142
Điện thoại16178712098
Trang webhttps://akebia.com/
Mã chứng khoánAKBA
Ngày IPOMar 20, 2014
Giám đốc điều hànhButler (John P)
Lãnh đạo công ty của Akebia Therapeutics Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. John P. Butler
Mr. John P. Butler
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.56M
+13.69%
Mr. John P. Butler
Mr. John P. Butler
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.56M
+13.69%
Ms. Carolyn M. Rucci
Ms. Carolyn M. Rucci
Senior Vice President, Chief Legal Officer and Secretary
Senior Vice President, Chief Legal Officer and Secretary
588.38K
-11.86%
Ms. Carolyn M. Rucci
Ms. Carolyn M. Rucci
Senior Vice President, Chief Legal Officer and Secretary
Senior Vice President, Chief Legal Officer and Secretary
588.38K
-11.86%
Mr. Adrian Adams
Mr. Adrian Adams
Independent Chairman of the Board
Independent Chairman of the Board
200.50K
+17.81%
Mr. Adrian Adams
Mr. Adrian Adams
Independent Chairman of the Board
Independent Chairman of the Board
200.50K
+17.81%
Mr. Michael W. Rogers
Mr. Michael W. Rogers
Independent Director
Independent Director
161.73K
+22.07%
Mr. Michael W. Rogers
Mr. Michael W. Rogers
Independent Director
Independent Director
161.73K
+22.07%
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
160.93K
+22.18%
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
160.93K
+22.18%
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. John P. Butler
Mr. John P. Butler
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.56M
+13.69%
Mr. John P. Butler
Mr. John P. Butler
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.56M
+13.69%
Ms. Carolyn M. Rucci
Ms. Carolyn M. Rucci
Senior Vice President, Chief Legal Officer and Secretary
Senior Vice President, Chief Legal Officer and Secretary
588.38K
-11.86%
Ms. Carolyn M. Rucci
Ms. Carolyn M. Rucci
Senior Vice President, Chief Legal Officer and Secretary
Senior Vice President, Chief Legal Officer and Secretary
588.38K
-11.86%
Mr. Adrian Adams
Mr. Adrian Adams
Independent Chairman of the Board
Independent Chairman of the Board
200.50K
+17.81%
Mr. Adrian Adams
Mr. Adrian Adams
Independent Chairman of the Board
Independent Chairman of the Board
200.50K
+17.81%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Akebia Therapeutics Inc?
Năm cổ đông hàng đầu của Akebia Therapeutics Inc là: Mr. John P. Butler
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Akebia Therapeutics Inc (AKBA)?
Tính đến ngày 2026Q1, có 351 tổ chức nắm giữ cổ phiếu của Akebia Therapeutics Inc, với tổng giá trị thị trường khoảng 125.97M, chiếm 46.96% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -14935721.00.